Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Amortization - Intangibles (2021 - 2024)

PAVmed has reported Amortization - Intangibles over the past 4 years, most recently at $105000.0 for Q2 2024.

  • For Q2 2024, Amortization - Intangibles fell 79.21% year-over-year to $105000.0; the TTM value through Dec 2024 reached $982000.0, down 51.39%, while the annual FY2024 figure was $559000.0, 72.34% down from the prior year.
  • Amortization - Intangibles for Q2 2024 was $105000.0 at PAVmed, down from $372000.0 in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $650000.0 in Q2 2022 and troughed at $17000.0 in Q3 2021.
  • A 4-year average of $368416.7 and a median of $505000.0 in 2022 define the central range for Amortization - Intangibles.
  • Biggest five-year swings in Amortization - Intangibles: surged 2870.59% in 2022 and later plummeted 79.21% in 2024.
  • Year by year, Amortization - Intangibles stood at $123000.0 in 2021, then skyrocketed by 311.38% to $506000.0 in 2022, then fell by 0.2% to $505000.0 in 2023, then plummeted by 79.21% to $105000.0 in 2024.
  • Business Quant data shows Amortization - Intangibles for PAVM at $105000.0 in Q2 2024, $372000.0 in Q1 2024, and $505000.0 in Q4 2023.